HealthEquity, Inc. (HQY) administers health savings accounts and complementary consumer-directed benefits for employers, benefits advisors, health plans, retirement plan providers, and healthcare consumers. Company updates commonly cover HSA account growth, HSA assets, service, custodial and interchange revenue, guidance, margin measures, stock repurchases, and actions to manage HSA cash repricing exposure.
News also includes board and executive governance changes, investor conference participation, research on healthcare affordability and HSA adoption, and product or platform themes tied to helping members save, spend and invest for healthcare.
HealthEquity reported Q1 FY23 revenue of $205.7 million, marking a 12% increase from $184.2 million in Q1 FY22. However, the company incurred a net loss of $13.6 million compared to $2.6 million in the previous year, with non-GAAP net income falling by 27% to $22.7 million. Adjusted EBITDA was $58.3 million, down 1%. The total number of HSAs increased by 26% to 7.4 million, with total HSA assets reaching $20.3 billion—a 35% increase. Outlook for FY23 projects revenues between $827 million and $837 million.
HealthEquity, the largest independent health savings account provider in the U.S., will announce its fiscal Q1 2023 financial results after market close on June 6, 2022. A conference call for investors will occur on the same day at 4:30 p.m. ET, allowing management to discuss the results. Additionally, HealthEquity will participate in the 2022 RW Baird Conference on June 7, 2022. For over 14 million accounts, HealthEquity partners with employers and advisors, focusing on enhancing consumer-directed benefits.
HealthEquity (NASDAQ: HQY) has released its second annual Corporate Social Responsibility (CSR) Report, highlighting advancements in ESG efforts and setting measurable goals for future improvement. The report emphasizes the company's commitment to transparency and includes a Materiality Assessment using recognized frameworks like the Global Reporting Initiative and Sustainability Accounting Standards Board. The company aims to enhance workforce diversity and create an inclusive environment, believing such efforts drive innovation and fulfill customer needs.
HealthEquity, Inc. (NASDAQ: HQY) announced the appointment of Rajesh (Nat) Natarajan to its Board of Directors, expanding the Board to 11 members, with 9 being independent. Natarajan brings over 25 years of experience in technology and product strategy, having held senior roles at notable companies like Globalization Partners and RingCentral. His expertise aligns with HealthEquity's growth objectives, focusing on innovation and enhancing product offerings. Chairman Robert Selander expressed confidence in Natarajan's ability to drive growth at HealthEquity, which serves over 14 million accounts.
Summary not available.
HealthEquity reported FY22 revenue of $756.6 million, up 3% year-over-year, but incurred a net loss of $44.3 million compared to net income of $8.8 million in FY21. Non-GAAP net income was $110.2 million, down from $127.6 million. The company closed significant acquisitions and increased HSA accounts by 25%, totaling 7.2 million HSAs. The outlook for FY23 anticipates revenues of $820 million to $830 million, with expected net losses between $61 million and $53 million.
Summary not available.
HealthEquity, Inc. (NASDAQ: HQY) announced it will report its fiscal year-end financial results on March 22, 2022, after market close. A conference call is scheduled for the same day at 4:30 PM ET, where management will discuss Q4 and fiscal year results ending January 31, 2022. The company also plans to present virtually at the KeyBank Virtual Life Sciences & Medtech Investor Forum on March 23, 2022. HealthEquity serves over 14 million accounts, focusing on connecting health and wealth.
HealthEquity, Inc. (NASDAQ: HQY) reported significant growth in HSA Assets and Total Accounts for the fiscal year ended January 31, 2022. HSAs increased by 25% to 7.2 million, while Total Accounts rose 12% to 14.4 million. HSA Assets reached $19.6 billion, a 37% increase from the previous year. The company also revised its FY22 revenue guidance to $754-$756 million and provided FY23 guidance of $815-$830 million. Despite a projected net loss between $54 million and $53 million, HealthEquity aims for continued market share growth in the HSA sector.
HealthEquity (HQY), the largest independent health savings account custodian in the U.S., will release its fiscal year-end sales results on February 22, 2022, after market close. A conference call is scheduled for the same day at 4:30 PM ET to discuss these results. Management will also attend several investor conferences, including the BTIG Virtual Medtech Conference on February 15, 2022, and the SVB Leerink Annual Global Healthcare Conference on February 16, 2022. A replay of the conference call will be available on the company's investor relations website.